Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA)

J. M. Evans, G. Cohen

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

2,4,5-Trihydroxyphenylalanine (6-OH-DOPA) destroys central and peripheral noradrenergic neurons, while sparing dopaminergic neurons. Previous studies indicate that 6-OH-DOPA toxicity is mediated by the formation of 6-hydroxydopamine. However, levels of 6-hydroxydopamine in brain following peripheral administration of 6-OH-DOPA have not been documented. In the current study, 6-OH-DOPA and 6-hydroxydopamine were measured in brain by HPLC with electrochemical detection after intraperitoneal injection of 6-OH-DOPA. when mice were injected with 100 mg 6-OH-DOPA/kg, 6-hydroxydopamine levels in the striatum were highest (1.9 μg/g) at 15 min and fell slowly to 24% of the peak value at 4 h. Experiments with reserpine indicated that the relative stability of 6-hydroxydopamine was largely dependent upon storage in synaptic vesicles. Reserpine (10 mg/kg) lowered striatal 6-hydroxydopamine levels to 21.6% of control (non-reserpine-treated) values at 1 h, and to 8.9% of control values at 4 h. Levels of 6-hydroxydopamine in the striatum at 1 h were increased 113% by pargyline (100 mg/kg), 145% by α-methyldopahydrazine (carbidopa; 25 mg/kg), and 261% by pargyline and carbidopa together. Levels of dopamine in the striatum were unchanged at 2.5 h after 200 mg 6-OH-DOPA/kg (with pargyline and 50 mg carbidopa/kg), whereas levels of norepinephrine in the frontal cortex fell by 77%. At the same time, 6-hydroxydopamine levels were 8.8-fold higher in the striatum (5.54 μg/g) than in the cortex (0.63 μg/g). The latter results show that the striatum is resistant to 6-OH-DOPA-mediated depletion of catecholamines even though the concentrations of 6-hydroxydopamine approach those of endogenous dopamine.

Original languageEnglish (US)
Pages (from-to)1461-1467
Number of pages7
JournalJournal of Neurochemistry
Volume52
Issue number5
StatePublished - 1989
Externally publishedYes

Fingerprint

Oxidopamine
Brain
Carbidopa
Pargyline
Reserpine
Neurons
Dopamine
6-hydroxydopa
Corpus Striatum
Adrenergic Neurons
hydroxide ion
Synaptic Vesicles
Dopaminergic Neurons
Frontal Lobe
Intraperitoneal Injections
Catecholamines
Toxicity
Norepinephrine
High Pressure Liquid Chromatography

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA). / Evans, J. M.; Cohen, G.

In: Journal of Neurochemistry, Vol. 52, No. 5, 1989, p. 1461-1467.

Research output: Contribution to journalArticle

@article{248b38a8c77b4e44b90d13db38e5e4ad,
title = "Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA)",
abstract = "2,4,5-Trihydroxyphenylalanine (6-OH-DOPA) destroys central and peripheral noradrenergic neurons, while sparing dopaminergic neurons. Previous studies indicate that 6-OH-DOPA toxicity is mediated by the formation of 6-hydroxydopamine. However, levels of 6-hydroxydopamine in brain following peripheral administration of 6-OH-DOPA have not been documented. In the current study, 6-OH-DOPA and 6-hydroxydopamine were measured in brain by HPLC with electrochemical detection after intraperitoneal injection of 6-OH-DOPA. when mice were injected with 100 mg 6-OH-DOPA/kg, 6-hydroxydopamine levels in the striatum were highest (1.9 μg/g) at 15 min and fell slowly to 24{\%} of the peak value at 4 h. Experiments with reserpine indicated that the relative stability of 6-hydroxydopamine was largely dependent upon storage in synaptic vesicles. Reserpine (10 mg/kg) lowered striatal 6-hydroxydopamine levels to 21.6{\%} of control (non-reserpine-treated) values at 1 h, and to 8.9{\%} of control values at 4 h. Levels of 6-hydroxydopamine in the striatum at 1 h were increased 113{\%} by pargyline (100 mg/kg), 145{\%} by α-methyldopahydrazine (carbidopa; 25 mg/kg), and 261{\%} by pargyline and carbidopa together. Levels of dopamine in the striatum were unchanged at 2.5 h after 200 mg 6-OH-DOPA/kg (with pargyline and 50 mg carbidopa/kg), whereas levels of norepinephrine in the frontal cortex fell by 77{\%}. At the same time, 6-hydroxydopamine levels were 8.8-fold higher in the striatum (5.54 μg/g) than in the cortex (0.63 μg/g). The latter results show that the striatum is resistant to 6-OH-DOPA-mediated depletion of catecholamines even though the concentrations of 6-hydroxydopamine approach those of endogenous dopamine.",
author = "Evans, {J. M.} and G. Cohen",
year = "1989",
language = "English (US)",
volume = "52",
pages = "1461--1467",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Studies on the formation of 6-hydroxydopamine in mouse brain after administration of 2,4,5-trihydroxyphenylalanine (6-hydroxyDOPA)

AU - Evans, J. M.

AU - Cohen, G.

PY - 1989

Y1 - 1989

N2 - 2,4,5-Trihydroxyphenylalanine (6-OH-DOPA) destroys central and peripheral noradrenergic neurons, while sparing dopaminergic neurons. Previous studies indicate that 6-OH-DOPA toxicity is mediated by the formation of 6-hydroxydopamine. However, levels of 6-hydroxydopamine in brain following peripheral administration of 6-OH-DOPA have not been documented. In the current study, 6-OH-DOPA and 6-hydroxydopamine were measured in brain by HPLC with electrochemical detection after intraperitoneal injection of 6-OH-DOPA. when mice were injected with 100 mg 6-OH-DOPA/kg, 6-hydroxydopamine levels in the striatum were highest (1.9 μg/g) at 15 min and fell slowly to 24% of the peak value at 4 h. Experiments with reserpine indicated that the relative stability of 6-hydroxydopamine was largely dependent upon storage in synaptic vesicles. Reserpine (10 mg/kg) lowered striatal 6-hydroxydopamine levels to 21.6% of control (non-reserpine-treated) values at 1 h, and to 8.9% of control values at 4 h. Levels of 6-hydroxydopamine in the striatum at 1 h were increased 113% by pargyline (100 mg/kg), 145% by α-methyldopahydrazine (carbidopa; 25 mg/kg), and 261% by pargyline and carbidopa together. Levels of dopamine in the striatum were unchanged at 2.5 h after 200 mg 6-OH-DOPA/kg (with pargyline and 50 mg carbidopa/kg), whereas levels of norepinephrine in the frontal cortex fell by 77%. At the same time, 6-hydroxydopamine levels were 8.8-fold higher in the striatum (5.54 μg/g) than in the cortex (0.63 μg/g). The latter results show that the striatum is resistant to 6-OH-DOPA-mediated depletion of catecholamines even though the concentrations of 6-hydroxydopamine approach those of endogenous dopamine.

AB - 2,4,5-Trihydroxyphenylalanine (6-OH-DOPA) destroys central and peripheral noradrenergic neurons, while sparing dopaminergic neurons. Previous studies indicate that 6-OH-DOPA toxicity is mediated by the formation of 6-hydroxydopamine. However, levels of 6-hydroxydopamine in brain following peripheral administration of 6-OH-DOPA have not been documented. In the current study, 6-OH-DOPA and 6-hydroxydopamine were measured in brain by HPLC with electrochemical detection after intraperitoneal injection of 6-OH-DOPA. when mice were injected with 100 mg 6-OH-DOPA/kg, 6-hydroxydopamine levels in the striatum were highest (1.9 μg/g) at 15 min and fell slowly to 24% of the peak value at 4 h. Experiments with reserpine indicated that the relative stability of 6-hydroxydopamine was largely dependent upon storage in synaptic vesicles. Reserpine (10 mg/kg) lowered striatal 6-hydroxydopamine levels to 21.6% of control (non-reserpine-treated) values at 1 h, and to 8.9% of control values at 4 h. Levels of 6-hydroxydopamine in the striatum at 1 h were increased 113% by pargyline (100 mg/kg), 145% by α-methyldopahydrazine (carbidopa; 25 mg/kg), and 261% by pargyline and carbidopa together. Levels of dopamine in the striatum were unchanged at 2.5 h after 200 mg 6-OH-DOPA/kg (with pargyline and 50 mg carbidopa/kg), whereas levels of norepinephrine in the frontal cortex fell by 77%. At the same time, 6-hydroxydopamine levels were 8.8-fold higher in the striatum (5.54 μg/g) than in the cortex (0.63 μg/g). The latter results show that the striatum is resistant to 6-OH-DOPA-mediated depletion of catecholamines even though the concentrations of 6-hydroxydopamine approach those of endogenous dopamine.

UR - http://www.scopus.com/inward/record.url?scp=0024584624&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024584624&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 1461

EP - 1467

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 5

ER -